These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29356912)

  • 21. Dynamic changes in insulin requirements with post-operative time using bedside artificial pancreas to maintain normoglycemia without hypoglycemia after cardiac surgery.
    Urai S; Hashimoto N; Takabe M; Kawashima M; Satake Y; Nishimoto Y; Kuroda M; Yamane Y; Doi K; Oue T; Murakami H; Mukohara N; Ohara T
    J Artif Organs; 2022 Mar; 25(1):72-81. PubMed ID: 34191199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perioperative tight glycemic control using artificial pancreas decreases infectious complications via suppression of inflammatory cytokines in patients who underwent pancreaticoduodenectomy: A prospective, non-randomized clinical trial.
    Akabori H; Tani M; Kitamura N; Maehira H; Imashuku Y; Tsujita Y; Shimizu T; Kitagawa H; Eguchi Y
    Am J Surg; 2020 Aug; 220(2):365-371. PubMed ID: 31836178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous Glucose Monitoring, Future Products, and Update on Worldwide Artificial Pancreas Projects.
    Kropff J; DeVries JH
    Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S253-63. PubMed ID: 26784131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Closed-Loop Control Without Meal Announcement in Type 1 Diabetes.
    Cameron FM; Ly TT; Buckingham BA; Maahs DM; Forlenza GP; Levy CJ; Lam D; Clinton P; Messer LH; Westfall E; Levister C; Xie YY; Baysal N; Howsmon D; Patek SD; Bequette BW
    Diabetes Technol Ther; 2017 Sep; 19(9):527-532. PubMed ID: 28767276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perioperative insulin therapy using a closed-loop artificial endocrine pancreas after hepatic resection.
    Okabayashi T; Maeda H; Sun ZL; Montgomery RA; Nishimori I; Hanazaki K
    World J Gastroenterol; 2009 Sep; 15(33):4116-21. PubMed ID: 19725143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Automated hybrid closed-loop control with a proportional-integral-derivative based system in adolescents and adults with type 1 diabetes: individualizing settings for optimal performance.
    Ly TT; Weinzimer SA; Maahs DM; Sherr JL; Roy A; Grosman B; Cantwell M; Kurtz N; Carria L; Messer L; von Eyben R; Buckingham BA
    Pediatr Diabetes; 2017 Aug; 18(5):348-355. PubMed ID: 27191182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance and safety of an integrated bihormonal artificial pancreas for fully automated glucose control at home.
    Blauw H; van Bon AC; Koops R; DeVries JH;
    Diabetes Obes Metab; 2016 Jul; 18(7):671-7. PubMed ID: 26996542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of basal insulin dosage on blood glucose concentration in ambulatory surgery patients with type 2 diabetes.
    Demma LJ; Carlson KT; Duggan EW; Morrow JG; Umpierrez G
    J Clin Anesth; 2017 Feb; 36():184-188. PubMed ID: 28183563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy and safety of simulated artificial pancreas in modulating stress hyperglycemia in critically ill patients: a prospective randomized controlled study].
    Yang Z; Tao G; Guo M; Sun B; Gong L; Ding Y; Ye S; Liu W; Yang X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Feb; 30(2):165-169. PubMed ID: 29402368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.
    Del Favero S; Place J; Kropff J; Messori M; Keith-Hynes P; Visentin R; Monaro M; Galasso S; Boscari F; Toffanin C; Di Palma F; Lanzola G; Scarpellini S; Farret A; Kovatchev B; Avogaro A; Bruttomesso D; Magni L; DeVries JH; Cobelli C; Renard E;
    Diabetes Obes Metab; 2015 May; 17(5):468-76. PubMed ID: 25600304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis.
    Bekiari E; Kitsios K; Thabit H; Tauschmann M; Athanasiadou E; Karagiannis T; Haidich AB; Hovorka R; Tsapas A
    BMJ; 2018 Apr; 361():k1310. PubMed ID: 29669716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overnight Glucose Control with Dual- and Single-Hormone Artificial Pancreas in Type 1 Diabetes with Hypoglycemia Unawareness: A Randomized Controlled Trial.
    Abitbol A; Rabasa-Lhoret R; Messier V; Legault L; Smaoui M; Cohen N; Haidar A
    Diabetes Technol Ther; 2018 Mar; 20(3):189-196. PubMed ID: 29393675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tight glycemic control using an artificial endocrine pancreas may play an important role in preventing infection after pancreatic resection.
    Hanazaki K
    World J Gastroenterol; 2012 Aug; 18(29):3787-9. PubMed ID: 22876028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Impact of Technology on Current Diabetes Management.
    Garvey K; Wolfsdorf JI
    Pediatr Clin North Am; 2015 Aug; 62(4):873-88. PubMed ID: 26210622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas.
    Bequette BW
    Diabetes Technol Ther; 2005 Feb; 7(1):28-47. PubMed ID: 15738702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The First Hybrid Closed-Loop Insulin Pump: Will It Meet Its Potential?
    Hirsch IB
    Diabetes Technol Ther; 2017 Mar; 19(3):140-141. PubMed ID: 28287847
    [No Abstract]   [Full Text] [Related]  

  • 37. The artificial pancreas: current status and future prospects in the management of diabetes.
    Peyser T; Dassau E; Breton M; Skyler JS
    Ann N Y Acad Sci; 2014 Apr; 1311():102-23. PubMed ID: 24725149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First use of model predictive control in outpatient wearable artificial pancreas.
    Del Favero S; Bruttomesso D; Di Palma F; Lanzola G; Visentin R; Filippi A; Scotton R; Toffanin C; Messori M; Scarpellini S; Keith-Hynes P; Kovatchev BP; Devries JH; Renard E; Magni L; Avogaro A; Cobelli C;
    Diabetes Care; 2014; 37(5):1212-5. PubMed ID: 24757228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target.
    Rossetti P; Quirós C; Moscardó V; Comas A; Giménez M; Ampudia-Blasco FJ; León F; Montaser E; Conget I; Bondia J; Vehí J
    Diabetes Technol Ther; 2017 Jun; 19(6):355-362. PubMed ID: 28459603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progressive artificial endocrine pancreas: The era of novel perioperative blood glucose control for surgery.
    Tsukamoto Y; Okabayashi T; Hanazaki K
    Surg Today; 2011 Oct; 41(10):1344-51. PubMed ID: 21922355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.